How big is the Oman Diabetes Drugs Market?

The Oman Diabetes Drugs Market size is expected to reach USD 212.26 million in 2024 and grow at a CAGR of 6.61% to reach USD 292.31 million by 2029. Read More

What is the current Oman Diabetes Drugs Market size?

In 2024, the Oman Diabetes Drugs Market size is expected to reach USD 212.26 million. Read More

Who are the key players in Oman Diabetes Drugs Market?

AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis and Eli Lilly and Company are the major companies operating in the Oman Diabetes Drugs Market. Read More

What years does this Oman Diabetes Drugs Market cover, and what was the market size in 2023?

In 2023, the Oman Diabetes Drugs Market size was estimated at USD 198.23 million. The report covers the Oman Diabetes Drugs Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Oman Diabetes Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Oman Diabetes Drugs Market Share

Statistics for the 2023 & 2024 Oman Diabetes Drugs market share, created by Mordor Intelligence™ Industry Reports. Oman Diabetes Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Oman Diabetes Drugs Industry

The Oman Diabetes Drugs Market is consolidated, with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca, and other generic players, holding a presence in the region. A major share of the market is held by manufacturers concomitant with strategy-based M&A operations and constantly entering the market to generate new revenue streams and boost existing ones.